Lv22
120 积分 2025-09-23 加入
Efficacy and safety of once-weekly semaglutide 2·0 mg versus 1·0 mg in patients with type 2 diabetes (SUSTAIN FORTE): a double-blind, randomised, phase 3B trial
18小时前
已完结
Future treatments for myelin oligodendrocyte glycoprotein antibody-associated disease: the clinical trial landscape
1个月前
已完结
NMOSD and MOGAD: an evolving disease spectrum
2个月前
已完结
Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria
2个月前
已完结
Immunotherapy in autoimmune encephalitis
2个月前
已完结
皖公网安备34019202002308
